The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
PPAR and human metabolic disease
Open accessAbstract
The nuclear receptor family of PPARs was named for the ability of the original member to induce hepatic peroxisome proliferation in mice in response to xenobiotic stimuli. However, studies on the action and structure of the 3 human PPAR isotypes (PPARalpha, PPARdelta, and PPARgamma) suggest that these moieties are intimately involved in nutrient sensing and the regulation of carbohydrate and lipid metabolism. PPARalpha and PPARdelta appear primarily to stimulate oxidative lipid metabolism, while PPARgamma is principally involved in the cellular assimilation of lipids via anabolic pathways. Our understanding of the functions of PPARgamma in humans has been increased by the clinical use of potent agonists and by the discovery of both rare and severely deleterious dominant-negative mutations leading to a stereotyped syndrome of partial lipodystrophy and severe insulin resistance, as well as more common sequence variants with a much smaller impact on receptor function. These may nevertheless have much greater significance for the public health burden of metabolic disease. This Review will focus on the role of PPARgamma in human physiology, with specific reference to clinical pharmacological studies, and analysis of PPARG gene variants in the abnormal lipid and carbohydrate metabolism of the metabolic syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R. E., & Tataranni, P. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7463 · Cited by 3,541
Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,529
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
Issemann, I., & Green, S. (1990) · Nature · doi:10.1038/347645a0 · Cited by 3,519
mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.
Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I., & Spiegelman, B. M. (1994) · Genes & Development · doi:10.1101/gad.8.10.1224 · Cited by 2,181
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
Yang, Q., Graham, T. E., Mody, N., Preitner, F., Peroni, O. D., Zabolotny, J. M., Kotani, K., Quadro, L., & Kahn, B. B. (2005) · Nature · doi:10.1038/nature03711 · Cited by 2,086
PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro
Rosen, E. D., Sarraf, P., Troy, A. E., Bradwin, G., Moore, K., Milstone, D. S., Spiegelman, B. M., & Mortensen, R. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80211-7 · Cited by 2,079
PPARγ Is Required for Placental, Cardiac, and Adipose Tissue Development
Barak, Y., Nelson, M. C., Ong, E. S., Jones, Y. Z., Ruiz-Lozano, P., Chien, K. R., Koder, A., & Evans, R. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80209-9 · Cited by 1,956
The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
Altshuler, D., Hirschhorn, J. N., Klannemark, M., Lindgren, C. M., Vohl, M.-C., Nemesh, J., Lane, C. R., Schaffner, S. F., Bolk, S., Brewer, C., et al. (2000) · Nature Genetics · doi:10.1038/79216 · Cited by 1,766
Maeda, N., Takahashi, M., Funahashi, T., Kihara, S., Nishizawa, H., Kishida, K., Nagaretani, H., Matsuda, M., Komuro, R., Ouchi, N., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.9.2094 · Cited by 1,659
Barroso, I., Gurnell, M., Crowley, V. E. F., Agostini, M., Schwabe, J. W., Soos, M. A., Maslen, G. L., Williams, T. D. M., Lewis, H., Schafer, A. J., et al. (1999) · Nature · doi:10.1038/47254 · Cited by 1,368
Self-citationPPARγ Mediates High-Fat Diet–Induced Adipocyte Hypertrophy and Insulin Resistance
Kubota, N., Terauchi, Y., Miki, H., Tamemoto, H., Yamauchi, T., Komeda, K., Satoh, S., Nakano, R., Ishii, C., Sugiyama, T., et al. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80210-5 · Cited by 1,342
Deeb, S. S., Fajas, L., Nemoto, M., Pihlajamäki, J., Mykkänen, L., Kuusisto, J., Laakso, M., Fujimoto, W., & Auwerx, J. (1998) · Nature Genetics · doi:10.1038/3099 · Cited by 1,319
The Organization, Promoter Analysis, and Expression of the Human PPARγ Gene
Fajas, L., Auboeuf, D., Raspé, E., Schoonjans, K., Lefebvre, A.-M., Saladin, R., Najib, J., Laville, M., Fruchart, J.-C., Deeb, S., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.30.18779 · Cited by 1,188
Schoonjans, K., Peinado‐Onsurbe, J., Lefebvre, A. M., Heyman, R. A., Briggs, M., Deeb, S., Staels, B., & Auwerx, J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00918.x · Cited by 1,173
Improvement in Glucose Tolerance and Insulin Resistance in Obese Subjects Treated with Troglitazone
Nolan, J. J., Ludvik, B., Beerdsen, P., Joyce, M., & Olefsky, J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411033311803 · Cited by 926
Adiponectin Expression From Human Adipose Tissue
Kern, P. A., Di Gregorio, G. B., Lu, T., Rassouli, N., & Ranganathan, G. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1779 · Cited by 875
Efficacy and Metabolic Effects of Metformin and Troglitazone in Type II Diabetes Mellitus
Inzucchi, S. E., Maggs, D. G., Spollett, G. R., Page, S. L., Rife, F. S., Walton, V., & Shulman, G. I. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381303 · Cited by 794
Vidal-Puig, A. J., Considine, R. V., Jimenez-Liñan, M., Werman, A., Pories, W. J., Caro, J. F., & Flier, J. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119424 · Cited by 786
Adiponectin – journey from an adipocyte secretory protein to biomarker of the metabolic syndrome
TRUJILLO, M. E., & SCHERER, P. E. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01426.x · Cited by 769
A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis
Promrat, K., Lutchman, G., Uwaifo, G. I., Freedman, R. J., Soza, A., Heller, T., Doo, E., Ghany, M., Premkumar, A., Park, Y., et al. (2004) · Hepatology · doi:10.1002/hep.20012 · Cited by 726
Miyazaki, Y., Mahankali, A., Matsuda, M., Mahankali, S., Hardies, J., Cusi, K., Mandarino, L. J., & DeFronzo, R. A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.6.8567 · Cited by 726
Yu, J. G., Javorschi, S., Hevener, A. L., Kruszynska, Y. T., Norman, R. A., Sinha, M., & Olefsky, J. M. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2968 · Cited by 725
Auboeuf, D., Rieusset, J., Fajas, L., Vallier, P., Frering, V., Riou, J. P., Staels, B., Auwerx, J., Laville, M., & Vidal, H. (1997) · Diabetes · doi:10.2337/diab.46.8.1319 · Cited by 697
Regulation of PPAR gamma gene expression by nutrition and obesity in rodents.
Vidal-Puig, A., Jimenez-Liñan, M., Lowell, B. B., Hamann, A., Hu, E., Spiegelman, B., Flier, J. S., & Moller, D. E. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118703 · Cited by 655
Yu, S., Matsusue, K., Kashireddy, P., Cao, W.-Q., Yeldandi, V., Yeldandi, A. V., Rao, M. S., Gonzalez, F. J., & Reddy, J. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210062200 · Cited by 619
Guan, Y., Hao, C., Cha, D. R., Rao, R., Lu, W., Kohan, D. E., Magnuson, M. A., Redha, R., Zhang, Y., & Breyer, M. D. (2005) · Nature Medicine · doi:10.1038/nm1278 · Cited by 608
PPARγ2 Regulates Adipose Expression of the Phosphoenolpyruvate Carboxykinase Gene
Tontonoz, P., Hu, E., Devine, J., Beale, E. G., & Spiegelman, B. M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.1.351 · Cited by 559
Combs, T. P., Pajvani, U. B., Berg, A. H., Lin, Y., Jelicks, L. A., Laplante, M., Nawrocki, A. R., Rajala, M. W., Parlow, A. F., Cheeseboro, L., et al. (2004) · Endocrinology · doi:10.1210/en.2003-1068 · Cited by 545
Motojima, K., Passilly, P., Peters, J. M., Gonzalez, F. J., & Latruffe, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.27.16710 · Cited by 524
Adams, M., Montague, C. T., Prins, J. B., Holder, J. C., Smith, S. A., Sanders, L., Digby, J. E., Sewter, C. P., Lazar, M. A., Chatterjee, V. K., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119870 · Cited by 517
Muscle-specific Pparg deletion causes insulin resistance
Hevener, A. L., He, W., Barak, Y., Le, J., Bandyopadhyay, G., Olson, P., Wilkes, J., Evans, R. M., & Olefsky, J. (2003) · Nature Medicine · doi:10.1038/nm956 · Cited by 492
YAMAMOTO, Y., HIROSE, H., SAITO, I., TOMITA, M., TANIYAMA, M., MATSUBARA, K., OKAZAKI, Y., ISHII, T., NISHIKAI, K., & SARUTA, T. (2002) · Clinical Science · doi:10.1042/cs1030137 · Cited by 490
Sanyal, A. J., Mofrad, P. S., Contos, M. J., Sargeant, C., Luketic, V. A., Sterling, R. K., Stravitz, R. T., Shiffman, M. L., Clore, J., & Mills, A. S. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00457-4 · Cited by 437
Savage, D. B., Tan, G. D., Acerini, C. L., Jebb, S. A., Agostini, M., Gurnell, M., Williams, R. L., Umpleby, A. M., Thomas, E. L., Bell, J. D., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.4.910 · Cited by 430
A futile metabolic cycle activated in adipocytes by antidiabetic agents
Guan, H.-P., Li, Y., Jensen, M. V., Newgard, C. B., Steppan, C. M., & Lazar, M. A. (2002) · Nature Medicine · doi:10.1038/nm780 · Cited by 428
Metabolic Effects of New Oral Hypoglycemic Agent CS-045 in NIDDM Subjects
Suter, S. L., Nolan, J. J., Wallace, P., Gumbiner, B., & Olefsky, J. M. (1992) · Diabetes Care · doi:10.2337/diacare.15.2.193 · Cited by 420
Norris, A. W., Chen, L., Fisher, S. J., Szanto, I., Ristow, M., Jozsi, A. C., Hirshman, M. F., Rosen, E. D., Goodyear, L. J., Gonzalez, F. J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17305 · Cited by 417
Miyazaki, Y., Mahankali, A., Matsuda, M., Glass, L., Mahankali, S., Ferrannini, E., Cusi, K., Mandarino, L. J., & DeFronzo, R. A. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.710 · Cited by 407
Yang, W.-S., Jeng, C.-Y., Wu, T.-J., Tanaka, S., Funahashi, T., Matsuzawa, Y., Wang, J.-P., Chen, C.-L., Tai, T.-Y., & Chuang, L.-M. (2002) · Diabetes Care · doi:10.2337/diacare.25.2.376 · Cited by 405
Improved insulin-sensitivity in mice heterozygous for PPAR-γ deficiency
Miles, P. D. G., Barak, Y., He, W., Evans, R. M., & Olefsky, J. M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8538 · Cited by 400
Biological control through regulated transcriptional coactivators
Spiegelman, B. M., & Heinrich, R. (2004) · Cell · doi:10.1016/j.cell.2004.09.037 · Cited by 377
Evidence for Gene-Nutrient Interaction at the PPAR γ Locus
Luan, J., Browne, P. O., Harding, A.-H., Halsall, D. J., O’Rahilly, S., Chatterjee, V. K. K., & Wareham, N. J. (2001) · Diabetes · doi:10.2337/diabetes.50.3.686 · Cited by 363
Ren, D., Collingwood, T. N., Rebar, E. J., Wolffe, A. P., & Camp, H. S. (2002) · Genes & Development · doi:10.1101/gad.953802 · Cited by 362
Biosynthesis of 15-deoxy-Δ12,14-PGJ2 and the ligation of PPARγ
Bell-Parikh, L. C., Ide, T., Lawson, J. A., McNamara, P., Reilly, M., & FitzGerald, G. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18012 · Cited by 341
Troglitazone action is independent of adipose tissue.
Burant, C. F., Sreenan, S., Hirano, K., Tai, T. A., Lohmiller, J., Lukens, J., Davidson, N. O., Ross, S., & Graves, R. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119839 · Cited by 334
The Peroxisome Proliferator-Activated Receptor-γ2 Pro12Ala Polymorphism
Stumvoll, M., & Häring, H. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2341 · Cited by 332
Zhang, H., Zhang, A., Kohan, D. E., Nelson, R. D., Gonzalez, F. J., & Yang, T. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501744102 · Cited by 317
Kelly, I. E., Han, T. S., Walsh, K., & Lean, M. E. (1999) · Diabetes Care · doi:10.2337/diacare.22.2.288 · Cited by 315
Memon, R. A., Tecott, L. H., Nonogaki, K., Beigneux, A., Moser, A. H., Grunfeld, C., & Feingold, K. R. (2000) · Endocrinology · doi:10.1210/endo.141.11.7771 · Cited by 302
Yang, Z., Strickland, D. K., & Bornstein, P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008925200 · Cited by 297
Beamer, B. A., Yen, C. J., Andersen, R. E., Muller, D., Elahi, D., Cheskin, L. J., Andres, R., Roth, J., & Shuldiner, A. R. (1998) · Diabetes · doi:10.2337/diabetes.47.11.1806 · Cited by 293
Maggs, D. G., Buchanan, T. A., Burant, C. F., Cline, G., Gumbiner, B., Hsueh, W. A., Inzucchi, S., Kelley, D., Nolan, J., Olefsky, J. M., et al. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-3-199802010-00002 · Cited by 286
Misra, A., Peethambaram, A., & Garg, A. (2004) · Medicine · doi:10.1097/01.md.0000111061.69212.59 · Cited by 285
Enhancement of adipocyte differentiation by an insulin-sensitizing agent.
Kletzien, R. F., Clarke, S. D., & Ulrich, R. G. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08890-x · Cited by 284
Larsen, T. M., Toubro, S., & Astrup, A. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.802223 · Cited by 282
Effect of troglitazone on body fat distribution in type 2 diabetic patients.
Mori, Y., Murakawa, Y., Okada, K., Horikoshi, H., Yokoyama, J., Tajima, N., & Ikeda, Y. (1999) · Diabetes Care · doi:10.2337/diacare.22.6.908 · Cited by 281
Agarwal, A. K., & Garg, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.1.8290 · Cited by 268
PPARG F388L, a Transactivation-Deficient Mutant, in Familial Partial Lipodystrophy
Hegele, R. A., Cao, H., Frankowski, C., Mathews, S. T., & Leff, T. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3586 · Cited by 264
Genetic Analysis of Adipogenesis through Peroxisome Proliferator-activated Receptor γ Isoforms
Mueller, E., Drori, S., Aiyer, A., Yie, J., Sarraf, P., Chen, H., Hauser, S., Rosen, E. D., Ge, K., Roeder, R. G., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206950200 · Cited by 246
Valve, R. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.10.3708 · Cited by 229
Plasma Adiponectin Levels in Overweight and Obese Asians
Yang, W., Lee, W., Funahashi, T., Tanaka, S., Matsuzawa, Y., Chao, C., Chen, C., Tai, T., & Chuang, L. (2002) · Obesity Research · doi:10.1038/oby.2002.150 · Cited by 220
Raskin, P., Rappaport, E. B., Cole, S. T., Yan, Y., Patwardhan, R., & Freed, M. I. (2000) · Diabetologia · doi:10.1007/s001250050045 · Cited by 216
Masugi, J., Tamori, Y., Mori, H., Koike, T., & Kasuga, M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2096 · Cited by 216
Sunder, M., Chang, A. R., & Henry, R. R. (2003) · Endocrine Practice · doi:10.4158/ep.9.5.406 · Cited by 209
Memisoglu, A. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg318 · Cited by 200
Regional Adiposity and Insulin Resistance
Garg, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0631 · Cited by 200
Robitaille, J., Després, J., Pérusse, L., & Vohl, M. (2003) · Clinical Genetics · doi:10.1034/j.1399-0004.2003.00026.x · Cited by 190
van Harmelen, V., Dicker, A., Rydén, M., Hauner, H., Lönnqvist, F., Näslund, E., & Arner, P. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2029 · Cited by 188
Satoh, H., Tsukamoto, K., Hashimoto, Y., Hashimoto, N., Togo, M., Hara, M., Maekawa, H., Isoo, N., Kimura, S., & Watanabe, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.0126 · Cited by 182
Tzameli, I., Fang, H., Ollero, M., Shi, H., Hamm, J. K., Kievit, P., Hollenberg, A. N., & Flier, J. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405346200 · Cited by 178
Thiazolidinediones Block Fatty Acid Release by Inducing Glyceroneogenesis in Fat Cells
Tordjman, J., Chauvet, G., Quette, J., Beale, E. G., Forest, C., & Antoine, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m206999200 · Cited by 178
Loviscach, M., Rehman, N., Carter, L., Mudaliar, S., Mohadeen, P., Ciaraldi, T. P., Veerkamp, J. H., & Henry, R. R. (2000) · Diabetologia · doi:10.1007/s001250050048 · Cited by 176
Bedoucha, M., Atzpodien, E., & Boelsterli, U. A. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00066-6 · Cited by 169
In vitro studies on the action of CS-045, a new antidiabetic agent
Ciaraldi, T. P., Gilmore, A., Olefsky, J. M., Goldberg, M., & Heidenreich, K. A. (1990) · Metabolism · doi:10.1016/0026-0495(90)90166-a · Cited by 164
Gervois, P. P., Vu‐Dac, N., Kleemann, R., Kockx, M., Dubois, G., Laine, B., Kosykh, V., Fruchart, J., Kooistra, T., & Staels, B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102839200 · Cited by 160
Digenic inheritance of severe insulin resistance in a human pedigree
Savage, D. B., Agostini, M., Barroso, I., Gurnell, M., Luan, J., Meirhaeghe, A., Harding, A.-H., Ihrke, G., Rajanayagam, O., Soos, M. A., et al. (2002) · Nature Genetics · doi:10.1038/ng926 · Cited by 159
Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARγ
Tsai, Y.-S., Kim, H.-J., Takahashi, N., Kim, H.-S., Hagaman, J. R., Kim, J. K., & Maeda, N. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420964 · Cited by 158
LIPOLYSIS:Contribution from Regional Fat
Jensen, M. D. (1997) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.17.1.127 · Cited by 157
Auboeuf, D., Rieusset, J., Lluis Fajas, A., Vallier, P., Frering, V., Riou, J. P., Staels, B., Auwerx, J. H., Laville, M., & Vidal, H. (1997) · Diabetes · doi:10.2337/diabetes.46.8.1319 · Cited by 152
Ek, J., Andersen, G., Urhammer, S. A., Hansen, L., Carstensen, B., Borch‐Johnsen, K., Drivsholm, T., Berglund, L., Hansen, T. K., Lithell, H., et al. (2001) · Diabetologia · doi:10.1007/s001250100629 · Cited by 150
Troglitazone Induces GLUT4 Translocation in L6 Myotubes
Yonemitsu, S., Nishimura, H., Shintani, M., Inoue, R., Yamamoto, Y., Masuzaki, H., Ogawa, Y., Hosoda, K., Inoue, G., Hayashi, T., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.5.1093 · Cited by 143
Olswang, Y., Cohen, H., Papo, O., Cassuto, H., Croniger, C. M., Hakimi, P., Tilghman, S. M., Hanson, R. W., & Reshef, L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022616299 · Cited by 140
Ye, J.-M., Dzamko, N. L., Cleasby, M. E., Hegarty, B. D., Furler, S. M., Cooney, G. J., & Kraegen, E. W. (2004) · Diabetologia · doi:10.1007/s00125-004-1436-1 · Cited by 138
Nicklas, B. J., van Rossum, E. F. C., Berman, D. M., Ryan, A. S., Dennis, K. E., & Shuldiner, A. R. (2001) · Diabetes · doi:10.2337/diabetes.50.9.2172 · Cited by 130
Neuschwander‐Tetri, B. A., Brunt, E. M., Wehmeier, K. R., Sponseller, C. A., Hampton, K., & Bacon, B. R. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00027-8 · Cited by 128
Rahimian, R., Masih‐Khan, E., Lo, M., van Breemen, C., McManus, B. M., & Dubé, G. P. (2001) · Molecular and Cellular Biochemistry · doi:10.1023/a:1011927113563 · Cited by 127
Doney, A. S. F., Fischer, B., Frew, D., Cumming, A. M., Flavell, D. M., WORLD, M. J., Montgomery, H., Boyle, D. I., Morris, A., & Palmer, C. N. (2002) · BMC Genetics · doi:10.1186/1471-2156-3-21 · Cited by 124
Edvardsson, U., Bergström, M. F., Alexandersson, M., Bamberg, K., Ljung, B., & Dahllöf, B. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33479-9 · Cited by 124
Andrulionyt�, L., Zacharova, J., Chiasson, J. L., Laakso, M., & for the STOP-NIDDM Study Group (2004) · Diabetologia · doi:10.1007/s00125-004-1577-2 · Cited by 123
Stümvoll, M., Wahl, H. G., Löblein, K., Becker, R., Machicao, F. E., Jacob, S., & Häring, H. U. (2001) · Diabetes · doi:10.2337/diabetes.50.4.876 · Cited by 116
Antidiabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442A cells
Sandouk, T., Reda, D. J., & Hofmann, C. A. (1993) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1993.264.6.c1600 · Cited by 113
Cha, B. S., Ciaraldi, T. P., Carter, L., Nikoulina, S. E., Mudaliar, S. R. D., Mukherjee, R., Paterniti, J. R., & Henry, R. R. (2001) · Diabetologia · doi:10.1007/s001250051642 · Cited by 112
Cole, S., Mitchell, B. D., Hsueh, W.-C., et al. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801210 · Cited by 105
Oh, E. Y., Min, K. M., Chung, J. H., Min, Y., Lee, M., Kim, K., & Lee, M.-K. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.5.6499 · Cited by 102
Lindi, V., Schwab, U., Louheranta, A. M., Laakso, M., Vessby, B. O., Hermansen, K., Storlien, L. H., Riccardi, G., & Rivellese, A. A. (2003) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(03)00065-9 · Cited by 97
Regional Differences in the Response of Human Pre-Adipocytes to PPARγ and RXRα Agonists
Sewter, C. P., Blows, F. M., Vidal‐Puig, A., & O’Rahilly, S. (2002) · Diabetes · doi:10.2337/diabetes.51.3.718 · Cited by 94
Meirhaeghe, A., Cottel, D., Amouyel, P., & Dallongeville, J. (2005) · Diabetes · doi:10.2337/diabetes.54.10.3043 · Cited by 91
Repression of IFN-γ Expression by Peroxisome Proliferator-Activated Receptor γ
Cunard, R. A., Eto, Y., Muljadi, J. T., Glass, C. K., Kelly, C., & Ricote, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7530 · Cited by 89
Franks, P. W., Luan, J., Browne, P. O., Harding, A.-H., O’Rahilly, S., Chatterjee, K., & Wareham, N. J. (2003) · Metabolism · doi:10.1016/j.metabol.2003.08.005 · Cited by 79
Freedman, B. D., Lee, E. J., Park, Y., & Jameson, J. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m407539200 · Cited by 78
Memişoğlu, A., Hu, F. B., Hankinson, S. E., Liu, S., Meigs, J. B., Altshuler, D., Hunter, D. J., & Manson, J. E. (2003) · Diabetes Care · doi:10.2337/diacare.26.10.2915 · Cited by 70
Poulsen, P., Andersen, G., Fenger, M., Hansen, T. F., Echwald, S. M., Vølund, A., Beck‐Nielsen, H., Pedersen, O. B., & Vaag, A. A. (2003) · Diabetes · doi:10.2337/diabetes.52.1.194 · Cited by 70
Glorian, M., Duplus, E., BEALE, E. G., Scott, D. K., Granner, D. K., & Forest, C. D. (2001) · Biochimie · doi:10.1016/s0300-9084(01)01343-8 · Cited by 67
Nakamura, Y., Ohya, Y., Onaka, U., Fujii, K., Abe, I., & Fujishima, M. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701669 · Cited by 67
Agostini, M., Gurnell, M., Savage, D. B., Wood, E. M., Smith, A. G., Rajanayagam, O., Garnes, K. T., Levinson, S. H., Xu, H. E., Schwabe, J. W. R., et al. (2003) · Endocrinology · doi:10.1210/en.2003-1271 · Cited by 66
Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects.
Frías, J. P., Yu, J., Kruszynska, Y. T., & Olefsky, J. M. (2000) · Diabetes Care · doi:10.2337/diacare.23.1.64 · Cited by 61
Kausch, C., Krützfeldt, J., Witke, A., Rettig, A., Bachmann, O. P., Kristian, R. E. T. T., Matthaei, S., Machicao, F. E., Häring, H., & Stümvoll, M. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4216 · Cited by 59
Adamo, K. B., Sigal, R. J., Williams, K., Kenny, G. P., Prud’homme, D., & Tesson, F. (2005) · Diabetologia · doi:10.1007/s00125-005-1827-y · Cited by 53
Sironi, A. M., Vichi, S., Gastaldelli, A., Pecori, N., Anichini, R., FOOT, E. A., Seghieri, G., & Ferrannini, E. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90068-0 · Cited by 52
Schneider, J. G., Kreuzer, J., Hamann, A., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.3.867 · Cited by 50
Savage, D. B., Murgatroyd, P. R., Chatterjee, V. K., & O’Rahilly, S. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1494 · Cited by 47
Malecki, M. T., Frey, J., Klupa, T., SKUPIEN, J. K., Waluś, M., Mlynarski, W. M., & Sieradzki, J. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(03)00164-5 · Cited by 45
A “futile cycle” induced by thiazolidinediones in human adipose tissue?
Tan, G. D., Debard, C., Tiraby, C., Humphreys, S. M., Frayn, K. N., Langin, D., Vidal, H., & Karpe, F. (2003) · Nature Medicine · doi:10.1038/nm0703-811 · Cited by 43
Semple, R. K., Meirhaeghe, A., Vidal‐Puig, A., Schwabe, J. W. R., Wiggins, D., Gibbons, G. F., Gurnell, M., Chatterjee, K., & O’Rahilly, S. (2005) · Endocrinology · doi:10.1210/en.2004-1405 · Cited by 41
Self-citationWeiss, E. P., Kulaputana, O., Ghiu, I. A., et al. (2004) · Metabolism · doi:10.1016/j.metabol.2004.08.006 · Cited by 40
Østergård, T., Ek, J., Hamid, Y. M. A., Saltin, B., Pedersen, O. B., Hansen, T. K., & Schmitz, O. (2005) · Hormone and Metabolic Research · doi:10.1055/s-2005-861174 · Cited by 40
Study of a new PPARγ2 promoter polymorphism and haplotype analysis in a French population
Meirhaeghe, A., Tanck, M. W. T., Fajas, L., Janot, C., Helbecque, N., Cottel, D., Auwerx, J. H., Amouyel, P., & Dallongeville, J. (2005) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2005.02.004 · Cited by 36
Bouassida, K. Z., Chouchane, L., Jellouli, K., Chérif, S., Haddad, S., Gabbouj, S., & Danguir, J. (2005) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70177-5 · Cited by 33
Poirier, O., Nicaud, V., Cambien, F., & Tiret, L. (2000) · Journal of Molecular Medicine · doi:10.1007/s001090000117 · Cited by 32
Increased insulin clearance in peroxisome proliferator-activated receptor γ2 Pro12Ala
Tschritter, O., Fritsche, A., Stefan, N., Haap, M. M., Thamer, C., Bachmann, O. P., Dahl, D. B., Maerker, E., Teigeler, A., Machicao, F. E., et al. (2003) · Metabolism · doi:10.1016/s0026-0495(03)00071-4 · Cited by 28
Takata, N., Awata, T., Inukai, K., Watanabe, M., Ohkubo, T., Kurihara, S., Inaba, M., & Katayama, S. (2004) · Metabolism · doi:10.1016/j.metabol.2004.06.022 · Cited by 27
Cited by
(1998) · PubMed · Cited by 2,737
Fat and Beyond: The Diverse Biology of PPARγ
Tontonoz, P., & Spiegelman, B. M. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.77.061307.091829 · Cited by 2,085
Wymann, M. P., & Schneiter, R. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2335 · Cited by 1,291
International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors
Michalik, L., Auwerx, J., Berger, J. P., Chatterjee, V. K., Glass, C. K., Gonzalez, F. J., Grimaldi, P. A., Kadowaki, T., Lazar, M. A., O’Rahilly, S., et al. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.4.5 · Cited by 1,000
Thomas, N., K, S., & Kapoor, N. (2016) · A Practical Guide to Diabetes Mellitus · doi:10.5005/jp/books/12651_7 · Cited by 943
Metadata
- Authors
- Semple, R. K.
- Venue
- Journal of Clinical Investigation
- Published
- 2006-03-01
- Volume
- 116
- Issue
- 3
- Pages
- 581-589
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2115414014
- Cited by
- 827
- References
- 124
- FWCI
- 29.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.